CNST Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 jan 1970 @ 01:00):

Stats
Dagens volum	1.27M
Gjennomsnittsvolum	1.57M
Markedsverdi	0.00
EPS	$0 ( 2021-08-03 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.734 (2.16%)

Insider Trading

Date	Person	Action	Amount	type
2021-07-15	Hoerter Steven L.	Sell	26 342	Stock Option (right to buy)
2021-07-15	Reeve Emma	Sell	60 000	Stock Option (Right to Buy)
2021-07-15	Reeve Emma	Sell	37 527	Stock Option (right to buy)
2021-07-15	Reeve Emma	Sell	73 428	Stock Option (right to buy)
2021-07-15	Reeve Emma	Sell	11 777	Stock Option (right to buy)

INSIDER POWER
0.00
Last 99 transactions
Buy: 291 157 \| Sell: 1 004 317

Volum Korrelasjon

Lang: 0.27 (neutral)

Kort: 0.71 (moderate)

Signal:(80.978) Neutral

Constellation Korrelasjon

10 Mest positive korrelasjoner
REAL	0.948
TLMD	0.947
MDWT	0.94
RMRM	0.926
ATOM	0.923
SVOK	0.923
MDXG	0.92
NNOX	0.918
WWD	0.918
NTAP	0.916

10 Mest negative korrelasjoner
BOCH	-0.944
IRWD	-0.943
ASTR	-0.927
XMTR	-0.921
APTX	-0.92
UPLD	-0.913
MMAC	-0.905
NETE	-0.903
EYE	-0.901
INGN	-0.896

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Constellation Korrelasjon - Valuta/Råvare

0.34
( neutral )

-0.45
( neutral )

0.18
( neutral )

0.31
( neutral )

-0.31
( neutral )

Constellation Økonomi

Annual	2020
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-4.49

FY	2020
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-4.49

FY	2019
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-3.04

FY	2018
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-5.00

Financial Reports:

No articles found.

Constellation

Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics to address serious unmet medical needs in patients with cancers associated with abnormal gene expression or drug resistance. Its lead product candidates include CPI-0610 that is in Phase II clinical trials for the treatment of patients with myelofibrosis in combination with ruxolitinib; and CPI-1205 that is in Phase Ib/II clinical trials for metastatic castration-resistant prostate cancer in combination with androgen receptor signaling inhibitors. The company is also developing CPI-0209 that is in Phase I dose escalation portion of a Phase I/II clinical trial to treat solid tumors. The company was formerly known as Epigenetix, Inc. and changed its name to Constellation Pharmaceuticals, Inc. in March 2008. Constellation Pharmaceuticals, Inc. was founded in 2008 and is based in Cambridge, Massachusetts.